An Open-Label, Randomized, 2-Part, Parallel Design Study to Characterize the Effect of Heparin on Palifermin Pharmacokinetics and the Effect of Palifermin on Heparin Pharmacodynamics in Healthy Subjects

Trial Profile

An Open-Label, Randomized, 2-Part, Parallel Design Study to Characterize the Effect of Heparin on Palifermin Pharmacokinetics and the Effect of Palifermin on Heparin Pharmacodynamics in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Dec 2014

At a glance

  • Drugs Heparin; Palifermin
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Sponsors Swedish Orphan Biovitrum
  • Most Recent Events

    • 27 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 27 Feb 2009.
    • 27 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 27 Feb 2009.
    • 27 Feb 2009 Biovitrum added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top